NEW CLASSES OF NEUROLOGICAL AND ANTIDEPRESSANTS, IN SOLID ORAL FORM, ORIENTED TO BOTH CONTRA (Q2035394): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: co-financing rate (P837): 50.00000033567024 percent) |
(Changed an Item) |
||||||
| Property / co-financing rate | |||||||
50.0 percent
| |||||||
| Property / co-financing rate: 50.0 percent / rank | |||||||
Normal rank | |||||||
Revision as of 04:32, 20 March 2020
Project in Italy financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | NEW CLASSES OF NEUROLOGICAL AND ANTIDEPRESSANTS, IN SOLID ORAL FORM, ORIENTED TO BOTH CONTRA |
Project in Italy financed by DG Regio |
Statements
1,489,557.14 Euro
0 references
2,979,114.26 Euro
0 references
50.0 percent
0 references
12 December 2016
0 references
6 July 2019
0 references
UNIVERSITA' DEGLI STUDI DI ROMA LA SAPIENZA
0 references
ITC FARMA
0 references
41°40'3.11"N, 12°30'17.24"E
0 references
L'IDEA PROGETTUALE CONSISTE NELLO SVILUPPO DI UN'AREA R&D E DI NUOVO IMPIANTO DI GRANULAZIONE INDUSTRIALE. LO SCOPO ? QUELLO DI RILANCIARE LA COMPETITIVIT? DELLA ITC FARMA SUL MERCATO DEI FARMACI GENERICI SEGUENDO DUE PERCORSI PARALLELI E SINERGICI, E (Italian)
0 references
Identifiers
F27H18000050007
0 references